These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4217996)

  • 1. [Dynamics of insulin secretion in terminal kidney failure and during chronic, intermittent dialysis treatment].
    Hübner W; Freiberg J; Fuss-Jahn B
    Verh Dtsch Ges Inn Med; 1974; 80():697-701. PubMed ID: 4217996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
    Redaelli B; Salvadeo A; Imbasciati E; Ponticelli C
    Arch Ital Urol Nefrol; 1967; 39(6):459-67. PubMed ID: 5606789
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin secretion in terminal renal insufficiency and following chronic intermittant hemodialysis].
    Hübner W; Potreck KH; Fuss-Jahn B
    Med Welt; 1974 May; 25(21):943-6. PubMed ID: 4209153
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
    Ikizler TA
    J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin catabolism in chronic uraemia and in anephric man before and after dialysis treatment.
    Navalesi R; Pilo A; Maggiore Q; Lenzi S; Cecchetti P; Donato L
    Proc Eur Dial Transplant Assoc; 1972; 9():119-25. PubMed ID: 4668904
    [No Abstract]   [Full Text] [Related]  

  • 7. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 8. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proceedings: Dynamics of insulin secretion in terminal kidney insufficiency and during chronic-intermittent dialysis treatment].
    Hübner W; Freiberg J; Fuss-Jahn B
    MMW Munch Med Wochenschr; 1974 May; 116(22):1106. PubMed ID: 4211588
    [No Abstract]   [Full Text] [Related]  

  • 10. Copper metabolism in uremia: effect of dialysis and zinc supplementation.
    Mahajan SK; Rye D; Sondheimer JH; McDonald FD
    Trans Am Soc Artif Intern Organs; 1985; 31():521-5. PubMed ID: 3837501
    [No Abstract]   [Full Text] [Related]  

  • 11. Extra-renal hormonal status in end-stage uraemia.
    Bhalla IP; Yashpal ; Garg VK; Malhotra S; Ohri VC; Rastogi DS
    J Assoc Physicians India; 1983 Aug; 31(8):493-5. PubMed ID: 6360987
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
    Kleinknecht D; Laudat MH; Strauch G; Jungers P; Laudat P
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):27-37. PubMed ID: 5041347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intermittent long-term dialysis in the light of 10-year experience].
    Gurland HJ
    Verh Dtsch Ges Inn Med; 1974; 80():645-53. PubMed ID: 4217993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of lipid metabolism in uremia].
    Cerezo Morales S; Escobar Jiménez F; Núñez Carril J; Asensio Peinado C; García-Valdescasa Valverde J; Raya Muñóz J; Peña Yáñez A
    Rev Clin Esp; 1978 Jan; 148(2):175-9. PubMed ID: 635270
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of the carbohydrate metabolism in renal insufficiency.
    Dzúrik R
    Rev Czech Med; 1974; 20(4):179-88. PubMed ID: 4438748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

  • 17. [The abnormalities of carbohydrate and lipid metabolism in uremia. A study in 20 hemodialyzed patients (author's transl)].
    Prinseau J; Meyrier A; Domart M; Brault D; Ragot J; Etienne J
    Sem Hop; 1980 Oct; 56(37-38):1491-6. PubMed ID: 6254168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucose tolerance in kidney insufficiency with and without dialysis treatment].
    Willms B; Quellhorst E; Scheler F
    Verh Dtsch Ges Inn Med; 1967; 73():1007-12. PubMed ID: 5591724
    [No Abstract]   [Full Text] [Related]  

  • 19. The London daily/nocturnal hemodialysis study: a review.
    Lindsay RM; Blagg CR
    Nephrol News Issues; 2003 Nov; 17(12):55-8. PubMed ID: 14640011
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine disorders in chronic hemodialysis patients (with the exclusion of hyperparathyroidism).
    Drüeke T
    Adv Nephrol Necker Hosp; 1981; 10():351-82. PubMed ID: 6267908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.